These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 21838139)

  • 21. Health insurance system in the Republic of Macedonia.
    Donev DM
    Croat Med J; 1999 Jun; 40(2):175-80. PubMed ID: 10234059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacists' participation in an inhaled respiratory medication program: reimbursement of professional fees.
    Murphy AL; MacKinnon NJ; Flanagan PS; Bowles SK; Sketris IS
    Ann Pharmacother; 2005 Apr; 39(4):655-61. PubMed ID: 15728330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community financing of health care.
    Carrin G
    World Health Forum; 1988; 9(4):601-6. PubMed ID: 3252870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinton reform proposal faces Congressional test on covered services, cost.
    Wash Memo Alan Guttmacher Inst; 1994 Jan; (1):1-3. PubMed ID: 12345517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients' perception of public, voluntary and private dispensaries in rural areas of Tanzania.
    Ahmed AM; Urassa DP; Gherardi E; Game NY
    East Afr Med J; 1996 Jun; 73(6):370-4. PubMed ID: 8840596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Private fee no barrier to family planning in the Czech Republic.
    Uzel R; Wynnyczuk V
    Plan Parent Eur; 1994 Mar; 23(1):10-1. PubMed ID: 12288979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost of patients with primary open-angle glaucoma: a retrospective study of commercial insurance claims data.
    Lee PP; Levin LA; Walt JG; Chiang T; Katz LM; Dolgitser M; Doyle JJ; Stern LS
    Ophthalmology; 2007 Jul; 114(7):1241-7. PubMed ID: 17306876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in drug utilization following the outpatient prescription drug cost-sharing program--evidence from Taiwan's elderly.
    Liu SZ; Romeis JC
    Health Policy; 2004 Jun; 68(3):277-87. PubMed ID: 15113639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Health economic impact of heart failure: An analysis of the nationwide German database].
    Zugck C; Müller A; Helms TM; Wildau HJ; Becks T; Hacker J; Haag S; Goldhagen K; Schwab JO
    Dtsch Med Wochenschr; 2010 Apr; 135(13):633-8. PubMed ID: 20333603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
    Hertz RP; Unger AN; Lustik MB
    Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multivariate analyses of patient financial systems and oral health-related quality of life.
    Johansson V; Axtelius B; Söderfeldt B; Sampogna F; Paulander J; Sondell K
    Community Dent Oral Epidemiol; 2010 Oct; 38(5):436-44. PubMed ID: 20545720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health care reform and change in public-private mix of financing: a Korean case.
    Jeong HS
    Health Policy; 2005 Oct; 74(2):133-45. PubMed ID: 16153474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Private health insurance in 1975: coverage, enrollment, and financial experience.
    Mueller MS
    Soc Secur Bull; 1977 Jun; 40(6):3-21. PubMed ID: 407657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wastage of medicines and its financial impact on the healthcare system in the Czech Republic.
    Smejkalová JKJKJKTAL
    Ceska Slov Farm; 2018 Dec; 67(5-6):192-199. PubMed ID: 30871324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GP responses to price regulation: evidence from a French nationwide reform.
    Coudin E; Pla A; Samson AL
    Health Econ; 2015 Sep; 24(9):1118-30. PubMed ID: 26197728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supplementary physicians' fees: a sustainable system?
    Calcoen P; van de Ven WPMM
    Health Econ Policy Law; 2019 Jan; 14(1):40-60. PubMed ID: 29366440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Development of financial participation of patients in the costs of pharmacotherapy in the years 2008-2012].
    Přikrylová E; Macešková B
    Ceska Slov Farm; 2013 Aug; 62(4):163-8. PubMed ID: 24047144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Satisfaction of supplementary insurance for medicinal services in war survivors in Iran.
    Mousavi B; Soroush M; Maftoon F; Mohammad K; Ayoubian A
    Med J Islam Repub Iran; 2019; 33():66. PubMed ID: 31456990
    [No Abstract]   [Full Text] [Related]  

  • 40. Insurance Fees from the Policy Holders' Standpoint.
    Cal State J Med; 1906 Aug; 4(8):225. PubMed ID: 18733910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.